Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor family 4 subfamily F member 21 (OR4F21) is listed as a human gene classified within the large family of olfactory receptors, which are G protein-coupled receptors (GPCRs) typically responsible for recognizing odorant molecules in the nose and mediate G protein signaling leading to the perception of smell[2][3][4]. However, in humans, **OR4F21 is annotated as a pseudogene**[2]. This means the gene likely does not encode a functional protein due to mutations or other genetic disruptions; thus, it is unlikely to have any normal biological function or direct disease role as a receptor. The olfactory receptor gene family is the largest in the human genome, with hundreds of pseudogenes that do not produce functional receptors[3][2]. No biological ligands, drugs, or clinical applications are known for OR4F21. There is no reported evidence that dysfunction or variation at this locus leads to any disease, nor is it a biomarker or therapeutic target. **Note**: Some database entries (such as the Ma'ayan Lab Harmonizome entry[2]) appear to conflate OR4F21 with unrelated RNA-binding proteins (e.g., hnRNP AB), but this is a likely error; authoritative sources classify OR4F21 as a pseudogene for an olfactory receptor, not an RNA-binding protein, and there is no peer-reviewed evidence to support a functional role outside canonical olfactory receptor GPCR biology. In summary: **OR4F21, also known as olfactory receptor 4F21, is a non-functional pseudogene in the human genome with no demonstrated physiological or pathological significance, and is not a clinical or drug target**[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 4 subfamily F member 21 (OR4F21).